Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 31 Oct 2024 08:00 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Third quarter 2024 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 24 Oct 2024 08:30 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Invitation to presentation of third quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Oct 2024 09:25 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics announces the death of its founder Dr. Erling Sundrehagen | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Sep 2024 15:07 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics ASA awarded European patent for novel NT-proBNP reference method | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Aug 2024 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Second quarter 2024 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 22 Aug 2024 10:00 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Invitation to presentation of second quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Aug 2024 11:20 CEST |
GENTIAN DIAGNOSTICS ASA | Appointment of Chief Technology Officer | 20103010 Biotechnology | Non-regulatory press releases |
| 31 Jul 2024 08:30 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics presents its NT-proBNP prototype at the ADLM | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Jul 2024 14:21 CEST |
GENTIAN DIAGNOSTICS ASA | Matti Heinonen (Arvela) appointed as CEO of Gentian Diagnostics | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Jun 2024 11:02 CEST |
GENTIAN DIAGNOSTICS ASA | Groundbreaking assay development for measuring total NT-proBNP levels | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Jun 2024 08:34 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: NT-proBNP successful completion of optimisation phase | 20103010 Biotechnology | Inside information |
| 02 May 2024 14:09 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Mandatory notificaton of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Apr 2024 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: First quarter 2024 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 29 Apr 2024 14:20 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2024 13:33 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Minutes from Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Apr 2024 09:46 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Invitation to presentation of first quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2024 09:15 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: CEO resignation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2024 09:15 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Notice of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2024 08:30 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics: Annual report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 13 Mar 2024 15:11 CET |
GENTIAN DIAGNOSTICS ASA | New KDIGO Guidelines recommends increased use of cystatin C | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Feb 2024 08:00 CET |
GENTIAN DIAGNOSTICS ASA | Fourth quarter and full year 2023 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 30 Jan 2024 14:04 CET |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of fourth quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Dec 2023 14:13 CET |
GENTIAN DIAGNOSTICS ASA | Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 18 Dec 2023 09:23 CET |
GENTIAN DIAGNOSTICS ASA | Resignation of board member | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Dec 2023 09:24 CET |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics presents at the DNB Nordic Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Dec 2023 13:29 CET |
GENTIAN DIAGNOSTIC | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Nov 2023 10:07 CET |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 26 Oct 2023 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Third quarter 2023 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 18 Oct 2023 12:19 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of third quarter results | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Sep 2023 13:41 CEST |
GENTIAN DIAGNOSTICS ASA | Expanding product portfolio with turbidimetric Retinol-Binding Protein (RBP) immunoassay | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Aug 2023 13:55 CEST |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Aug 2023 08:00 CEST |
GENTIAN DIAGNOSTICS ASA | Second quarter 2023 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2023 09:34 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of second quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Jun 2023 08:38 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian acquires Getica for SEK 3.0 million | 20103010 Biotechnology | Non-regulatory press releases |
| 10 May 2023 10:42 CEST |
GENTIAN DIAGNOSTICS ASA | Capital Markets Day at 12.30 CEST today | 20103010 Biotechnology | Non-regulatory press releases |
| 08 May 2023 14:41 CEST |
GENTIAN DIAGNOSTICS ASA | Reminder: Invitation to Capital Markets Day 10 May 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 05 May 2023 17:25 CEST |
GENTIAN DIAGNOSTICS ASA | Disclosure of shareholdings – Holta Invest AS | 20103010 Biotechnology | Major shareholding notifications |
| 05 May 2023 17:05 CEST |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 05 May 2023 07:30 CEST |
GENTIAN DIAGNOSTICS ASA | First quarter 2023 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 04 May 2023 11:18 CEST |
GENTIAN DIAGNOSTICS ASA | Minutes from Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Apr 2023 10:55 CEST |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of first quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Apr 2023 09:24 CEST |
GENTIAN DIAGNOSTICS ASA | Gentian Diagnostics invites to Capital Markets Day | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Apr 2023 13:12 CEST |
GENTIAN DIAGNOSTICS ASA | Notice of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Mar 2023 16:48 CEST |
GENTIAN DIAGNOSTICS ASA | Annual report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 22 Mar 2023 13:52 CET |
GENTIAN DIAGNOSTICS ASA | Health economic model identifies GCAL® as a cost-effective biomarker | 20103010 Biotechnology | Non-regulatory press releases |
| 17 Mar 2023 15:45 CET |
GENTIAN DIAGNOSTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2023 08:00 CET |
GENTIAN DIAGNOSTICS ASA | Fourth quarter and full year 2022 report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 15 Feb 2023 13:24 CET |
GENTIAN DIAGNOSTICS ASA | New study addresses the use of plasma calprotectin in sepsis management | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Feb 2023 13:42 CET |
GENTIAN DIAGNOSTICS ASA | Invitation to presentation of fourth quarter results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Dec 2022 12:50 CET |
GENTIAN DIAGNOSTICS ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |